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ABSTRACT
ELT-2 is the major regulator of genes involved in differentiation,
maintenance and function of C. elegans intestine from the early
embryo to mature adult. elt-2 responds to overexpression of the
GATA transcription factors END-1 and END-3, which specify the
intestine, as well as to overexpression of the two GATA factors that
are normally involved in intestinal differentiation, ELT-7 and ELT-2
itself. Little is known about the molecular mechanisms underlying
these interactions, how ELT-2 levels are maintained throughout
development or how such systems respond to developmental
perturbations. Here, we analyse elt-2 gene regulation through
transgenic reporter assays, ELT-2 ChIP and characterisation of
in vitro DNA-protein interactions. Our results indicate that elt-2 is
controlled by three discrete regulatory regions conserved between
C. elegans and C. briggsae that span >4 kb of 5′ flanking sequence.
These regions are superficially interchangeable but have
quantitatively different enhancer properties, and their combined
activities indicate inter-region synergies. Their regulatory activity
is mediated by a small number of conserved TGATAA sites that are
largely interchangeable and interact with different endodermal
GATA factors with only modest differences in affinity. The
redundant molecular mechanism that forms the elt-2 regulatory
network is robust and flexible, as loss of end-3 halves ELT-2 levels in
the early embryo but levels fully recover by the time of hatching.
When ELT-2 is expressed under the control of end-1 regulatory
elements, in addition to its own endogenous promoter, it can replace
the complete set of endoderm-specific GATA factors: END-1, END-
3, ELT-7 and (the probably non-functional) ELT-4. Thus, in addition
to controlling gene expression during differentiation, ELT-2 is
capable of specifying the entire C. elegans endoderm.
KEY WORDS: Caenorhabditis elegans, Endoderm development,
Transcription, GATA factor, ELT-2, ChIP-Seq
INTRODUCTION
The C. elegans endoderm provides an experimentally accessible and
relatively simple example of a transcriptional network that drives the
development of an entire tissue, namely the intestine (reviewed by
McGhee, 2013). The core transcription factors have been identified
and their functional roles are understood at the level of genetics and
cell biology. Current investigations focus on understanding the
network at a biochemical level: (1) to define direct interactions
between transcription factors and their target genes and (2) to
understand how this regulatory network functions quantitatively
(Maduro et al., 2015; Nair et al., 2013; Raj et al., 2010).
The entire C. elegans intestine (endoderm or E lineage) is
produced from cells that descend from the single E blastomere of the
eight-cell embryo (Fig. 1) (Sulston et al., 1983). Endoderm
specification occurs when the genes encoding two small GATA-
type transcription factors, END-1 and END-3, are transcriptionally
activated only in the E blastomere (Maduro et al., 2005; Owraghi
et al., 2009). In the current model of the endoderm regulatory
network (Fig. 1), END-1 and END-3 activate transcription of the
gene encoding the next factor in the endoderm regulatory cascade,
the GATA factor ELT-7, at the 2E cell stage (Nair et al., 2013;
Sommermann et al., 2010). The gene encoding the final factor in the
cascade, the GATA factor ELT-2, is activated slightly later (at the 4E
cell stage for most embryos) (Fukushige et al., 1998; Nair et al.,
2013; Raj et al., 2010) and remains active into adulthood. It has been
proposed that ELT-2 participates in the transcription of every gene
expressed in the differentiating and mature intestine (with the likely
exception of ribosomal protein genes), binding directly to TGATAA
sites in intestinal gene promoters (McGhee et al., 2009, 2007). Loss
of elt-2 is completely lethal, whereas loss of elt-7 has no obvious
phenotype (Fukushige et al., 1998; McGhee et al., 2007;
Sommermann et al., 2010), implying that END-1 and END-3
might interact directlywith the elt-2 promoter. In the absence of elt-2,
the intestine is malformed but clearly specified and quite well
differentiated (Fukushige et al., 1998). Loss of elt-7 exacerbates the
elt-2 loss-of-function phenotype (Sommermann et al., 2010), but
even the elt-7; elt-2 double-mutant intestine is reasonably well
formed, suggesting that END-1 and/or END-3 might also be able to
activate early genes of intestinal differentiation. However,most of the
direct interactions implied by this network are yet to be demonstrated.
Here, we address several questions. How is transcription of the
elt-2 gene controlled?Which of the other endodermal GATA factors
participate directly? Are there a small number of crucial cis-acting
sites in the elt-2 promoter or are there large numbers of redundant
sites, thereby providing possible insights into network behaviour?
Do perturbations of the regulatory network persist or do they self-
correct? Finally, what is the nature of the extensive redundancy
within the endoderm network? Do individual factors have unique
properties as proteins, or is it their expression timing that is
important? As a partial answer to these last two questions, we show
that ELT-2, if expressed under the control of the end-1 promoter in
addition to its own promoter, is able to replace the entire set of
endoderm-specific GATA factors: END-1, END-3, ELT-7 and (the
probably non-functional) ELT-4. Thus, ELT-2 alone can both
specify the endoderm and regulate intestine differentiation and
maintenance.Received 21 September 2015; Accepted 12 December 2015
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RESULTS
Defining the elt-2 upstream regulatory region
Fig. 2A (top) shows anti-ELT-2 antibody staining in staged wild-
type embryos: ELT-2 protein is never detected in 1E cell stages, is
rarely (<1%) detected in 2E cell stages but is invariably detected by
the 4E cell stage. Strong intestine-specific expression continues in
later embryonic stages as well as in larvae and adults (8E and 1.5-
fold stages are shown in Fig. 2A; adult staining is shown in
Fig. S1A) (see also Fukushige et al., 1998). Fig. S1B provides
evidence for the specificity of the antibody. As also shown in
Fig. 2A (bottom), the native ELT-2 expression pattern is adequately
reproduced by a transgenic reporter, in which 5048 bp of elt-2 5′
flanking region is used to drive expression of a nuclear-localised
GFP reporter. GFP fluorescence is first detected weakly at the 4E
cell stage and much more strongly at the 8E cell stage. This short
time lag in reporter expression is consistent with the expected 30
min delay introduced by GFP folding and/or maturation (Iizuka
et al., 2011) and, as expected, stronger 4E cell expression of the
reporter can be detected by an anti-GFP antibody (data not shown).
To define cis-acting influences on elt-2 transcription, genomic
sequences were compared for the 6 kb upstream of the elt-2 genes
from C. elegans and the related nematode C. briggsae. A dot matrix
comparison (Fig. 2B) detects three conserved regions (CRs): CR I
(∼ −0.6 to 0 kb), which contains the transcriptional start site at
−499 bp (Kruesi et al., 2013); CR II (∼−2.2 to−1.5 kb); and CR III
(∼ −4.4 to −3.3 kb). Pairwise sequence alignments are shown in
Fig. S2. Roughly similar regions of conservation can be detected
when the C. elegans elt-2 promoter is aligned with those from
C. brenneri and C. remanei, but only CR III can be detected in the
more distantly related nematode C. japonicum (data not shown).
Previous experiments and existing chromosomal deletions define
limits to functional regions within the elt-2 promoter. A 4.3 kb
promoter fragment driving a C-terminal ELT-2::GFP fusion (with
an unc-54 3′UTR) rescues the otherwise 100% lethal elt-2 (ca15)
null mutation [construct pJM86 in Fukushige et al. (1999)].
Deletion ca16, which removes elt-4, and deletion gk153, which
removes the distal half of CR III and much of the open reading frame
(ORF) C39B10.7 (Fig. 2B), have no measureable effect on brood
size, defecation rate or growth rate [Fukushige et al. (2003) and
Fig. S3, respectively]. We conclude that: (1) all necessary regulatory
information lies within 5 kb upstream of the elt-2 gene and (2)
sequences removed by deletion ca16 or gk153 are not required for
adequate elt-2 expression.
The three conserved promoter regions contribute
synergistically to the initiation and maintenance of elt-2
expression
The results of two opposing deletion series (5′ and 3′) of an elt-
2prom::GFP-lacZ reporter construct, assayed in transgenic
embryos, are collected in Fig. S4. Reporter expression decreases
abruptly as the proximal region of CR III is removed from either
Fig. 2. Transcriptional regulation of the elt-2 gene. (A) The expression of
transgenic reporters accurately reflects the in vivo expression of ELT-2. The top
row shows the normal endogenous expression patterns of ELT-2 in early
C. elegans embryos, as detected by immunofluorescence using the anti-ELT-2
monoclonal antibody 455-2A4. The middle row shows expression patterns in
early to mid-stage embryos of a transgenic nuclear-localised GFP reporter
construct driven by the 5048 bp 5′ flanking region of the elt-2 gene. Egg shells
are outlined (dashed line). Beneath is a differential interference contrast (DIC)
image of an L1 larva, with the fluorescence from the transgenic elt-2::GFP
reporter superimposed. Scale bar: 20 μm. In each image, fluorescence signal
is adjusted to high contrast to emphasize expression patterns and the lack of
non-intestinal expression. (B) Identifying conserved regions in the elt-2 5′
control region by sequence alignments. The dot matrix plot (EMBOSS/
dotmatcher, www.ebi.ac.uk/tools/emboss) compares 6 kb upstream of the
ATG initiation codon for C. elegans (horizontal axis) and C. briggsae (vertical
axis), revealing three blocks of conserved sequences (CR I, CR II and CR III).
These conserved blocks are aligned with the genomic locus of the C. elegans
elt-2 gene, showing (to scale and from left to right) the upstream elt-4 gene, the
apparent ORF C39B10.7 and the elt-2 coding region with the transcriptional
start site (TSS) indicated. Also shown are two genomic deletions (ca16 and
gk153), TGATAA sites (filled triangles) and WGATAR sites that are not
TGATAA (open circles).
Fig. 1. Regulatory network consisting of the four zygotically expressed
endoderm-specific GATA-type transcription factors that specify and
differentiate the C. elegans early endoderm (E lineage). Time scale
(minutes after first cell division at 20°C) is shown on the left. In the centre are
images of three early stages of embryogenesis: the 1E, 2E and 4E cells are
indicated by white dots. The current model for the roles and regulatory relations
between the various transcription factors is shown on the right.
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direction. These results are consistent with two interpretations: (1)
the proximal region of CR III contains a site crucial for elt-2
expression in the embryo or (2) the elt-2 promoter contains multiple
distributed sites contributing to activity, the proximal region of CR
III being the point where a critical number of these sites has been
removed in either deletion series such that overall promoter activity
now falls below a threshold.
To distinguish between these two models, CR I, CR II and CR III
were fused individually and in combinations to a GFP reporter.
Constructs were assessed for ‘initiation’ activity (expression at the
4E to 8E cell stage of transgenic embryos) and ‘maintenance’
activity (expression from the comma stage embryo through the
larval and adult stages). When CR III, CR II and CR I are fused
directly to each other and to the GFP reporter (Fig. 3A, Construct
#1), expression is strong and robust, starting at the 4E cell stage
(again, allowing for maturation time lag of GFP) and continuing
to adulthood. Within experimental uncertainty, expression levels
approximate to those produced by the full unmodified 5 kb
promoter assayed with the same reporter, suggesting that all
necessary or even influential cis-acting regulatory motifs are
contained within the three conserved regions.
CR I in isolation (Fig. 3A, Construct #2) is neither able to initiate
reporter expression at the 4E cell stage nor able tomaintain expression
past hatching but does significantly contribute to expression during
the mid-to-late embryonic stages. CR II in isolation (Construct #3) is
unable to drive detectable reporter expression at any stage. By
contrast, CR III in isolation (Construct #4) is able to drive expression
from the earliest initiation phase (4E) and at all subsequent stages into
adulthood. CR III (which is perhaps augmented in its activity by basal
promoter activity associated with the unannotated ORF C39B10.7;
Fig. 2B) thus appears to provide the strongest contribution of the three
individual conserved regions to elt-2 transcriptional activity, both in
initiation and in maintenance phases. However, when the conserved
regions are combined pairwise (Fig. 3A, Constructs #5-7), they show
clear synergy. That is, together the conserved regions are able to drive
higher levels of reporter expression at more stages than the estimated
sum of the activities of the two tested individual conserved regions.
Part of the apparent synergy between CR III and CR I could be
because CR I provides a basal promoter activity for CR III.When CR
III is fused to a non-endodermal basal promoter (containing no
TGATAA sites) from the C. elegans heat shock gene (Construct #8),
reporter activity is indistinguishable from that of the CR III-CR I
combination in Construct #7.
The synergies observed between the three conserved regions
appear incompatiblewith the model in which transcription of elt-2 is
controlled by a crucial site situated in the proximal region of CR III
but do appear compatible with the alternative interpretation of there
being multiple cis-acting motifs distributed throughout the
conserved regions that all contribute to promoter activity. Under
this model, if the summed contributions of some subclass or
combination of these cis acting sites lie above a threshold, elt-2 is
transcribed. The results also provide evidence against a model in
which each conserved region contributes solely and uniquely to a
spatial subpattern of activity (for example, to elt-2 expression in the
anterior or posterior intestine) or is solely responsible for elt-2
expression during a restricted developmental time window (for
example, only in embryos or only in L1 larvae).
Conserved TGATAA sites are individually dispensable but
collectively crucial for elt-2 control
Of the 30 potential GATA factor binding sites (defined as
WGATAR) in the genomic region depicted in Fig. 2B, 22 are
TGATAA, the site highly enriched in promoters of intestinal genes
(McGhee et al., 2009, 2007; Pauli et al., 2006); this proportion
(∼73%) is more than twice that expected from base composition and
applies to the overall region as well as to each of the three conserved
regions. It would be an overwhelming task to mutate these
individual sites combinatorially and comprehensively, especially
without a precise quantitative assay. The present analysis is thus
limited to mutating four conserved TGATAA sites in CR III and
three conserved TGATAA sites plus a conserved AGATAG site in
CR I.
As noted above, CR III fused to the basal heat shock promoter
(Fig. 3A, Construct #8) produces strong expression from the 4E
stage to adulthood. However, this activity is completely abolished
by mutation of the four conserved TGATAA sites in CR III
(Fig. 3B, Construct #9). Likewise, no activity is observed when a
quadruply mutated CR III is combined with a quadruply mutated
CR I (Fig. 3B, Construct #10). When an unmutated CR I or CR III
is fused to a quadruply mutated CR III or CR I, respectively
(Fig. 3B, Constructs #11,12), the resulting activity is close to that
provided by the unmutated regions assayed in isolation. These
results suggest that for CR III (and for CR I with the caveat that one
of the mutated sites was AGATAG), TGATAA sites are necessary
to provide enhancer activity. Further, the results suggest that there
are no non-TGATAA sites that are sufficient for driving elt-2
expression.
Each of the four TGATAA sites in CR III were mutated one at a
time and then assayed as a fusion to an unmutated CR I (Fig. 3B,
Constructs #13). Expression patterns produced by each of the four
constructs are essentially indistinguishable and are similar to that
produced by the unmutated CR III-CR I fusion (Construct #7). We
conclude that there is no single TGATAA site within CR III that is
necessary or obviously distinguished from the others. When two or
even three of the four CR III TGATAA sites are mutated (Fig. 3B,
Constructs #14, 15), expression remains strong.
END-1, ELT-7 and ELT-2 can bind in vitro to conserved
TGATAA sites in the elt-2 promoter
The above results show that CR III appears to be involved in both
the initiation and maintenance of elt-2 transcription. Electrophoretic
mobility shift experiments show that END-1 (involved in elt-2
initiation), ELT-2 (involved in elt-2 maintenance) and ELT-7
(probably involved in both elt-2 initiation and maintenance) can all
bind in vitro to each of the four conserved TGATAA sites in CR III
(Fig. 4A). Binding is specific in that it is competed efficiently by
unlabelled double-stranded oligonucleotide but is competed much
less efficiently by unlabelled oligonucleotides in which the
TGATAA sites have been mutated to GTCGAC. Allowing for
different specific activities of labelling of the four probes, for each
of the three proteins we estimate that binding affinities to the
individual TGATAA sites in CR III differ by at most 5- to 10-fold.
These biochemical measurements support the general view derived
from the previous transgenic experiments, namely that each
TGATAA site contributes to overall promoter activity, even
though individual sites may differ several fold in their influence.
ELT-2 binds directly in vivo to its own promoter and to
promoters of intestinal differentiation genes
To test for direct ELT-2 occupancy at its own promoter in vivo, we
performed chromatin immunoprecipitation and sequencing (ChIP-
Seq) using an antibody specific to C. elegans ELT-2 (as used in
Fig. 2A and Fig. S3) and extracts derived from wild-type L3 larvae.
Within the elt-2 promoter, three regions of ELT-2 occupancy can be
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identified that passed our threshold of significance (MACS2 peak
scores <10−30) and that aligned satisfactorily with CR I, CR II and
CR III (Fig. 5, Fig. S5). Thus, the ChIP-Seq results support the view
that ELT-2 interacts with all three of the conserved cis-regulatory
regions in the elt-2 promoter. A peak of ELT-2 occupancy (below
our significance threshold) can be detected upstream of the elt-4
gene, suggesting that ELT-2 might also regulate elt-4. Fig. S6 shows
that the expression of an integrated elt-4 promoter::GFP transgenic
reporter is largely abolished by elt-2 RNAi.
An extensive ChIP-Seq analysis of ELT-2 binding to intestinal
differentiation genes at different developmental stages will be
provided elsewhere (E.O.N., J.D.L. and J.D.M., unpublished).
However, the present ChIP-Seq data allow us to illustrate the direct
binding of ELT-2 to two previously characterised intestinal
differentiation genes, ges-1 (gut esterase) and cpr-6 (cysteine
protease). As shown in Fig. 5B, a significant peak of ELT-2
occupancy can be detected 1.1 kb upstream of the ges-1 initiation
codon, aligning with the tandem pair of GATA sites (TGATAA and
TGATAG) that have previously been shown to be functional in
transgenic assays (Egan et al., 1995) and that were originally used to
clone elt-2 (Hawkins and McGhee, 1995). In L1 larvae, levels of
cpr-6 transcripts decrease ∼100-fold in the absence of ELT-2
(McGhee et al., 2009) and a prominent peak of ELT-2 aligns with a
TGATAA site immediately upstream of the cpr-6 coding sequence
(Fig. 5C).
ELT-2 levels recover from early perturbation caused by lack
of END-3
Both quantitative in situ hybridisation and transgenic reporter assays
show that loss of end-3 significantly decreases the level of elt-2
transcripts at the 4E to 8E cell stage (Boeck et al., 2011; Raj et al.,
2010). Yet loss of end-3 results in only 5-10% of embryos that lack
an intestine (Maduro et al., 2007, 2005). Indeed, we determined that
brood sizes in homozygous end-3(-) adults are essentially wild
type [244±29 (n=1220) for end-3(-) adults, 253±33 (n=1265) for
N2 (±s.d.); P=0.7, t-test]. Thus, either animals can survive and
thrive with only a fraction of their normal ELT-2 levels, or the
ELT-2 levels recover later in development.
ELT-2 protein levels in 8E cell stage end-3(-) embryos were
measured by quantitative immunofluorescence and found to be
50±20% of those in 8E cell stage wild-type embryos
(weighted mean±s.d. from three independent immunofluorescence
comparisons, n=513 embryos), consistent with previous estimates
(Raj et al., 2010; Boeck et al., 2011). Because immunofluorescence
Fig. 3. Enhancer activities of the three conserved regions
identified in the 5′ flanking region of elt-2. (A) The enhancer
activity of CR I, CR II and CR III was tested individually and in
combinations. Reporter expression patterns from multiple
independent transgenic lines are summarised as: +++, similar
pattern and intensity as the intact 5 kb promoter; ++ and +,
decreasing (∼by half ) steps in intensity; −, no detectable reporter
expression. (B) Importance of conserved TGATAA sites in CR III and
CR I for elt-2 enhancer activity. Mutated TGATAA sites are marked
by ‘X’.
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of individual embryos during later stages of embryogenesis was too
variable, we used quantitative western blotting to measure ELT-2
levels in newly hatched end-3(-) and wild-type L1 larvae (Fig. S7).
We first established conditions in which the measured band
intensity of a paramyosin UNC-15 control increased by 2.0±0.3-
fold when twice the number of animals were loaded on the gel. From
band intensities measured with three different loadings of both N2
and end-3(ok1448) L1 larvae (extracts of 500, 1000 and 2000
animals per lane) on each of two independent gels, we estimate that
the ELT-2 levels in end-3(-) L1 larvae are 108±23% (±s.d.) of the
UNC-15-normalised ELT-2 levels measured in N2 L1 larvae
(P=0.4, t-test; thus not significantly different from 100%).
Therefore, ELT-2 levels in end-3(-) animals have reattained wild-
type levels by the time of hatching.
ELT-2 expressed earlier in development can replace all other
endodermal GATA factors
In the course of normal C. elegans development, either END-1 or
END-3 is necessary to specify the C. elegans endoderm (Maduro
et al., 2015; Owraghi et al., 2009), whereas initial ELT-2 function is
restricted to differentiation. We examined whether ELT-2 could
replace END-1 and END-3 in specifying the endoderm, simply by
being expressed earlier. If so, this would be a striking result, because
these endodermal GATA factors have overall amino acid identities
and similarities of only 12-24%.
We attempted to rescue an end-1 end-3 double mutant by
injecting a construct in which elt-2 cDNA is under the control of
either the end-1 or end-3 promoter. Strain MS1248 [end-1(ok558)
end-3(ok1448); irEx568 [end-1(+); end-3(+); sur-5::RFP];
Owraghi et al., 2009] was injected so as to install a second
extrachromosomal transgenic array containing, for example, end-
1prom::elt-2 cDNA, together with elt-2prom::GFP and rol-6
(su1006) marker constructs. Successful rescue was indicated by
progeny worms that had lost the original rescuing array but had
retained the replacement array, thereby producing green non-red
rollers. Rescue was judged to be unsuccessful if such segregants
could not be detected after several generations. Initial observations
showed that both end-3prom::elt-2 cDNA and end-1prom::elt-2
cDNA constructs were able to rescue the end-1 end-3 double
mutant. Subsequent experiments were performed with the end-
1prom::elt-2 cDNA construct because it gave more efficient rescue.
To establish a stable rescuing construct, one particular rescuing
Fig. 4. DNA-protein interactions in the elt-2 control region. Electrophoretic
mobility shift assays to show that END-1, ELT-2 and ELT-7 proteins can all bind
directly to each of the four conserved TGATAA sites in CR III of the elt-2
promoter. The same set of labelled probes was used for all three proteins, with
the coordinates of the individual conserved TGATAA sites shown at the top.
Fig. 5. ELT-2 ChIP-Seq on the elt-2, ges-1 and cpr-6 loci. (A) ELT-2 ChIP-
Seq tracks (dark blue) from L3 larval worms are shown on and around the elt-2
gene, with significant MACS2 peaks highlighted above (dark blue bars). ChIP-
Seq reads were normalised with respect to read depth and IgG-only controls.
The average of three replicates is shown. Individual replicates are shown in
Fig. S5. The corresponding RNA-Seq (light blue) results obtained from the
same chromatin preparation (whole L3 worms) are shown below. Regions of
poor mappability owing to genomic repeats are depicted in the Repeatmasker
(www.repeatmasker.org) trace (grey). The location of CR I, CR II and CR III and
the occurrences of TGATAAmotifs are also shown. (B,C) ELT-2 ChIP-Seq and
RNA-Seq tracks at the (B) ges-1 and (C) cpr-6 loci.
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array was integrated into a wild-type background, followed by
outcrossing to remove extraneous mutations. This strain (JM230
caIs85[end-1prom::elt-2 cDNA; elt-2prom::GFP; pRF4] I) serves
as a control for phenotypes that are not connected to the rescuing
ability of the transgenic array. The integrated array caIs85 was then
introduced into a quadruple homozygous null mutant in end-1,
end-3, elt-7 and elt-4.
The final rescued strain (JM229 caIs85; elt-7 end-1 end-3; elt-4)
is surprisingly viable, healthy and fertile. JM229 shows only 3±4%
embryonic lethality and 12±9% larval lethality (nine broods, 1467
total progeny), corresponding to an overall rescuing rate of ∼85%.
Control strain JM230 caIs85 shows 2% and 0% embryonic and
larval lethality, respectively, suggesting that the 15% overall
lethality observed with JM229 is due to incomplete rescue and
not to any unrelated property associated with the rescuing array. The
rescued strain JM229 shows roughly the same level of lethality/
arrest as seen with an end-3 single mutant: we measured embryonic
and larval lethality/arrest in strain RB1331 end-3(ok1448) as 3±3%
and 12±7%, respectively (four broods, 912 total progeny); Maduro
et al. (2007) previously reported that 5% of end-3(ok1448) embryos
lack an intestine. Early embryonic phenotypes of JM229 (20°C) are
mild and resemble the incomplete rescue of the end-3 null
phenotype described previously (Boeck et al., 2011). Specifically,
the 2E cell stage is 2-4 min shorter than in control embryos, the 2E-
to-4E cell division occurs closer to the ventral surface of the embryo
[10±2 μm for JM229 (n=19); 15±1 μm for the N2 control (n=8);
15±1 μm for control strain JM230 (n=17)], and the division axis
tends to be oriented in a more dorsoventral direction than normal.
The most severe overall embryonic phenotype of the rescued strain
is that the duration of embryogenesis (the time from the 2- to 4-cell
stage to hatching) is extended by ∼1 h compared with N2 and with
the control strain JM230 (Fig. 6A).
An image of a newly hatched L1 larva of the rescued strain
JM229 is shown in Fig. 6B. The number of intestinal nuclei is
normal (20.1±0.8, n=31) as counted using the elt-2prom::GFP
reporter that is part of the rescuing array (Fig. 6C). JM229 L1 larvae
are 13-15% shorter than control L1 larvae [242±20 μm for JM229
(n=31); 284±25 μm for JM230 (n=32); 278±18 for N2 (n=30)]. The
heads of rescued larvae sometimes appear more rounded than
normal (compare the JM229 L1 shown in Fig. 6Bwith thewild-type
L1 shown in Fig. 6D). The overall life cycle (time from 2- to 4-cell
stage to first egg lay) is extended (∼84 h for JM229 compared with
∼60 h for the N2 control) but a similar delay is measured with the
control strain JM230 and is thus more likely to reflect a property of
the rescuing array than incomplete rescue. The most severe post-
hatching phenotype is that the brood size is reduced [163±65 (n=9)
for JM229; 262±52 (n=5) for N2; 221±28 (n=5) for JM230].
However, with respect to morphology and overall viability, the
JM229 phenotypes are remarkably minor.
Using the same assay, we were unable to rescue the quadruple
elt-7 end-1 end-3; elt-4 mutant with a single copy of the
end-1prom::elt-2 cDNA construct inserted into the ttTi5605
MosCI site on chromosome II (Frøkjaer-Jensen et al., 2012).
Thus, elt-2 overexpression in the early embryo might be a key
feature of its ability to rescue the quadruple mutant. ELT-2 protein
can always be detected immunologically in the 2E cell stage of
JM229 embryos, which is one cell cycle earlier than it appears in
wild-type embryos. However, the majority of JM229 1E cell
embryos are ELT-2 negative, suggesting that there could be
functional levels of ELT-2 below our detection limit or that
endoderm specification can occur at the 2E cell stage. As assayed by
immunofluorescence, a 2E cell stage JM229 embryo contains
roughly the same amount of ELT-2 protein as found in an 8E to 16E
cell stage wild-type embryo (data not shown). In other words, ELT-
2 is indeed overexpressed in the earliest embryos of the rescued
strain but not exceptionally so.
elt-7 cDNA expressed under the control of the end-1 promoter in
a multicopy transgenic array was also able to rescue the quadruple
elt-7 end-1 end-3; elt-4 mutant. As expected, this rescue required
elt-2 (McGhee et al., 2007; Sommermann et al., 2010). However,
not all GATA factors can specify the C. elegans endoderm. We used
the end-1 promoter to drive expression of cDNAs of either the
C. elegans hypodermis-specific GATA factor ELT-3 (Gilleard et al.,
1999) or the mouse endodermal GATA transcription factor GATA4
(Aronson et al., 2014), but neither construct was able to rescue the
end-1 end-3 double mutant.
DISCUSSION
The C. elegans elt-2 gene is controlled by three conserved
‘enhancers’ distributed over ∼5 kb of 5′ flanking region. Each of
these three regions contributes to the transcriptional activation of
elt-2 but the exact contribution depends on which of the other
Fig. 6. ELT-2 can replace END-1, END-3, ELT-7 and ELT-4. (A) Embryos
from the rescued quadruplemutant strain JM229 (black circles) hatch later than
embryos from the control strain JM230 (white circles). Other symbols represent
hatching curves measured for four different local versions of N2 wild-type
worms (including a recent thaw). Time on the x-axis is minutes at 20°C from the
1- to 4-cell stage of embryogenesis. (B) DIC image of an L1 larva from the
rescued quadruple mutant strain JM229. Average length of JM229 L1 larvae is
242±20 μm. (C) Fluorescent image of the same larva as in B, showing
expression of an elt-2prom::GFP reporter incorporated into the integrated
rescuing array caIs85. (D) DIC image of an L1 larva from N2 wild-type control.
Average length of N2 L1 larvae is 278±18 μm.
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conserved regions are included in the construct. In other words, the
three enhancers appear to interact with each other and to contribute
synergistically to overall elt-2 activity. At the present level of our
analysis, there is no evidence of any particular subpattern of
expression (e.g. adult stage only or anterior intestine only) being
conveyed by any particular enhancer; rather, they all seem to
contribute to overall elt-2 transcriptional activity.
Focusing on two of the elt-2 enhancers (CR I and CR III), we
showed that mutation of all conserved TGATAA sites (four in CR
III, three in CR I plus an AGATAG site) abolished both enhancer
and basal promoter activity when assayed in transgenic reporters.
We conclude that these conserved sites are necessary for elt-2
expression and that no other site within the enhancers is sufficient
for reporter expression (barring sites that overlap with the mutated
TGATAA sites). Thus, we have no evidence that the core
developmental control of elt-2 expression is mediated by anything
other than conserved TGATAA sites and, by implication, by the
known set of endodermal GATA factors: END-1/3 and ELT-2/7.
However, we fully expect that there will be other types of intestinal
transcription factors and other cis-acting sites that, at least in post-
embryonic stages, participate in elt-2 control, maintaining
physiological homeostasis and responding to nutritional or
environmental signals.
The transcriptional activity of the most active enhancer, CR III,
persisted even with only one remaining wild-type TGATAA site, at
least qualitatively. Furthermore, we could find no evidence that any
individual TGATAA site was functionally distinct from any other;
for example, being solely responsible for the initiation of elt-2
transcription or responsive to only one of the several GATA factors
present in the early endoderm. This model is supported by the
in vitro demonstration that END-1, ELT-7 and ELT-2 could all bind
directly to each of the four conserved TGATAA sites within CR III.
Even though different sites showed modestly different affinities for
the different factors, we were not able to identify a ‘GATA’ site to
which one factor could bind but another factor could not (note that
END-3 protein was not available).
The above results lead to a model for elt-2 control that is
redundant, robust and flexible. Indeed, when ELT-2 levels are
halved by loss of end-3 in the early embryo, they are able to recover
to wild-type levels by the time that the animals hatch, several hours
later. Thus, the endoderm network is capable of dynamic re-
equilibration or self-correction during embryogenesis. A different
perturbation of the early endoderm regulatory network has recently
been shown to lead to increased numbers of intestinal nuclei in the
adult (Maduro et al., 2015). It will be important to determine if such
adult phenotypes are due to a persistent perturbation of the
transcriptional network and its downstream biochemical pathways
or are rather due to some irreversible early cellular defect, such as
aberrant cell division in the early embryo.
An unexpected result of the present study is the demonstration
that ELT-2, when expressed under a transgenic end-1 promoter as
well as under its own endogenous promoter, is able to replace,
essentially completely, the other four GATA factors involved in
development of the C. elegans endoderm, namely END-1, END-3,
ELT-7 and (for completeness) ELT-4. Rescue is highly efficient
using a multiple copy transgene of end-1prom::elt-2 cDNA, but is
not perfect. The strain has low levels of embryonic/larval lethality,
slightly perturbed gastrulation, marginally slower embryonic
development and a lower brood size. However, overall, we regard
these phenotypes as remarkably modest considering the extensive
rearrangement of the core transcriptional network. We were unable
to achieve rescue of the quadruple elt-7 end-1 end-3; elt-4 mutant
using a single integrated copy of the end-1prom::elt-2 cDNA
transgene. This failure could possibly reflect a position effect,
although single-copy insertions of end-1 into this same genomic
locus appear to function well (Maduro et al., 2015). Alternatively,
perhaps the larger ELT-2 molecule takes longer to be produced than
the smaller END-1 and/or END-3 molecules (see below), or perhaps
ELT-2 binds less optimally to the early endoderm-specifying genes
that are the normal targets of END-1/END-3. Both of these
inefficiencies might require that ELT-2 is expressed at higher levels
in order to compensate.
Regulatory pathways are thought to evolve in a retrograde
manner, with genes expressed late brought under control of factors
expressed earlier, which in turn are brought under the control of
factors expressed even earlier (Wilkins, 1995). Thus, genes
encoding intestinal digestive enzymes or intestinal structural
proteins might originally have been under the sole control of
ELT-2. ELT-2 might subsequently have come under control of the
earlier expressed end-1 and end-3, with the redundant activation of
elt-2 by elt-7 introduced as an intermediate step or as a later
intercalation.
In light of the demonstration that ELT-2 can perform all necessary
functions of END-1, END-3 and ELT-7, why did the C. elegans
endoderm pathway evolve as it did and not remain with only
ELT-2 as the transcriptional activator of the genes performing
specification, differentiation, growth and intestinal maintenance?
Three reasons come to mind. The first reason is possible selection
for greater fidelity of endoderm development controlled by a
redundant pathway (Cooke et al., 1997). A second possible reason is
to separate elt-2 control from the influence of skn-1 and pop-1, the
two maternal-effect genes that activate end-1 and end-3 in the E
blastomere. Both skn-1 and pop-1 also function zygotically within
the differentiating and mature intestine and the transient expression
of end-1 and end-3 would free ELT-2 from being controlled by
skn-1 and/or pop-1 throughout the animal’s lifespan. A third reason
could be that the use of the smaller end-1 and end-3 genes allows
more rapid transcription and translation and hence more rapid
specification of the E cell than if specification depended on elt-2.
The differences are greatest when comparing end-3 and elt-2. The
transcript lengths are 1276 and 2344 nucleotides, respectively;
protein sizes are 242 and 433 amino acids, respectively. Cell cycle
times in the early C. elegans embryo are only 15-20 min, perhaps
providing sufficient time for end-3 but not elt-2 to be transcribed
and translated. In the early Drosophila embryo, cell cycle times are
even shorter and it has been shown that the transcription of long
genes is aborted by the intervention of mitosis (Shermoen and
O’Farrell, 1991). However, elt-2 (∼2.3 kb) is much shorter than the
Drosophila gene (Ubx, 57 kb), the transcription of which is aborted
by mitosis, and to our knowledge it has not yet been shown that
similar mitosis-aborted transcription occurs in early C. elegans
development. Moreover, our rescuing transgene is based on elt-2
cDNA, which is roughly the same size as the end-3 transcript,
suggesting that perhaps it is translation that is limiting, not
transcription. In any event and independent of any particular
explanation, the quadruple mutant elt-7(-) end-1(-) end-3(-); elt-4(-)
embryos rescued by the end-1prom::elt-2 cDNA transgene hatch
∼1 h later than wild-type embryos, a potentially huge fitness
disadvantage.
The C. elegans endoderm is one of only several developmental
cell lineages in which a plausible direct molecular chain of
command can be proposed to connect factors in the maternal
cytoplasm with factors controlling tissue-specific gene transcription
in the mature adult. In the present paper, we have defined core
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features of both the cis-acting sequences and the trans-acting
factors controlling transcription of the gene encoding ELT-2, the
predominant transcription factor associated with endoderm
differentiation and function. We have provided a clear example of
how the regulatory network is able to overcome a severe early
perturbation, namely the low concentration of ELT-2 in the early
embryo caused by loss of the end-3 gene. Finally, we have explored
the regulatory potential of the ELT-2 protein and have shown that it
is capable of replacing all other endodermal GATA factors, in
particular replacing the END-1 and END-3 factors that normally
specify the endoderm. Our results contribute to a long-term goal of
describing development of the C. elegans endoderm quantitatively,
in terms of binding affinities for particular regulatory sites and in
terms of transcription factor activities, redundancies and stabilities.
MATERIALS AND METHODS
Nematode strains
C. elegans strains were grown on OP50-seeded NGM plates (Brenner,
1974). Transgenic animals were produced by standard gonadal injection
(Mello et al., 1991), with the DNA construct to be tested present at
25-50 µg/ml, usually together with pRF4 at 50 µg/ml as a phenotypic
marker. Plasmids were constructed by standard methods and are described
in more detail in the supplementary Materials and Methods. Selected
transforming arrays were integrated into the genome using γ-irradiation as
previously described (Egan et al., 1995), followed by outcrossing at least
four times. The full genotype of the rescued quadruple mutant strain JM229
is: caIs85[end-1prom::elt-2cDNA (pJM513), rol-6(su1006) (pRF4),
elt-2prom::GFP (pJM370) I]; elt-7(tm840) end-1(ok558) end-3(ok1448)
V; elt-4(ca16) X. The genotype of the control strain JM230 is: caIs85 I. All
mutant alleles of the GATA factor genes are deletions (presumed nulls) and
were followed in genetic crosses by PCR; primer sequences and expected
product sizes are detailed in Table S1. The homozygosity of the end-1
deletion in the final strain JM229 was also verified by Southern blotting.
The end-1prom::elt-2 cDNA sequence was cloned into plasmid pCFJ350
(Addgene) and a single copy inserted into chromosome II using strain
EG6699 and the MosCI technique developed by Frøkjaer-Jensen et al.
(2012).
Antibodies and immunodetection
The anti-ELT-2 monoclonal antibody 455-2A4 (isotype IgG1) used in
immunofluorescence, ChIP and western blotting was produced by the
Southern Alberta Cancer Research Institute Antibody Services, using as
antigen a purified polyhistidine-tagged full-length ELT-2 protein produced
in E. coli. Immunostaining of embryos dissected from adult hermaphrodites
was performed as described (Van Furden et al., 2004). Western blots were
performed by standard methods, probed with anti-ELT-2 monoclonal
antibody 455-2A4 together with monoclonal antibody MH16
(Developmental Studies Hybridoma Bank, University of Iowa) to detect
paramyosin as a loading control and developed with HRP-conjugated
secondary antibodies and the Amersham ECL Prime reagent. Band
intensities were measured with a LAS4000 Imaging Station (GE
Healthcare) and quantitated using Fiji. Further details of the antibodies
used and immunodetection methods are provided in the supplementary
Materials and Methods.
DNA-protein interactions
Electrophoretic mobility shift assays (band shifts) were performed as
previously described (Kalb et al., 1998). The four TGATAA sites (with
10 bp flanking sequence on either side) were all synthesized as self-
complementary hairpins (four C residues in the loop) to guarantee equal
stoichiometry and a double-stranded conformation. Only the wild-type
hairpin was used as a labelled probe, in which case a missing 3′ terminal C
residue was filled in using Klenow polymerase and α32P-dCTP. Binding
specificities were tested using competition with non-labelled hairpins at a
50-fold excess. Full-length His-tagged END-1, ELT-7 and ELT-2 proteins
were synthesized in baculovirus-infected insect cells, either by ourselves or
by ARVYS Proteins Inc., and purified by metal-affinity chromatography
(estimated purity >90%).
Chromatin immunoprecipitation followed by deep sequencing
(ChIP-Seq)
ChIP-Seq was performed and the datawere analysed as previously described
(Berkseth et al., 2013). ChIP-Seq and RNA-Seq methods, analysis
parameters and instructions for data access (GEO accession numbers) are
described in detail in the supplementaryMaterials andMethods, with ELT-2
ChIP-Seq peaks and summits listed in Tables S2 and S3.
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